mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.0009 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |